Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7943 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7485 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7485 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7469 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7207 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7174 |
Intermediate Similarity |
NPD5951 |
Approved |
0.717 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7153 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD37 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7097 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7067 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6190 |
Approved |
0.705 |
Intermediate Similarity |
NPD2629 |
Approved |
0.703 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7023 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7713 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD8313 |
Approved |
0.6994 |
Remote Similarity |
NPD8312 |
Approved |
0.6993 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD5126 |
Approved |
0.6993 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3748 |
Approved |
0.6989 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6948 |
Remote Similarity |
NPD2438 |
Suspended |
0.6941 |
Remote Similarity |
NPD7228 |
Approved |
0.694 |
Remote Similarity |
NPD164 |
Approved |
0.6918 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6905 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6902 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6901 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6894 |
Remote Similarity |
NPD7798 |
Approved |
0.689 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.689 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6861 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD5402 |
Approved |
0.6839 |
Remote Similarity |
NPD5405 |
Approved |
0.6839 |
Remote Similarity |
NPD5404 |
Approved |
0.6839 |
Remote Similarity |
NPD5406 |
Approved |
0.6839 |
Remote Similarity |
NPD5408 |
Approved |
0.6826 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD2067 |
Discontinued |
0.681 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.68 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6782 |
Remote Similarity |
NPD7240 |
Approved |
0.6776 |
Remote Similarity |
NPD6663 |
Approved |
0.6772 |
Remote Similarity |
NPD3750 |
Approved |
0.6768 |
Remote Similarity |
NPD7411 |
Suspended |
0.675 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD3226 |
Approved |
0.6747 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6733 |
Remote Similarity |
NPD5736 |
Approved |
0.6732 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6731 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6731 |
Remote Similarity |
NPD2796 |
Approved |
0.673 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD5403 |
Approved |
0.6727 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6725 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6721 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6721 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6714 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.671 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6708 |
Remote Similarity |
NPD2532 |
Approved |
0.6708 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD2534 |
Approved |
0.6708 |
Remote Similarity |
NPD5401 |
Approved |
0.6708 |
Remote Similarity |
NPD2533 |
Approved |
0.6702 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.669 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6688 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6688 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6686 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6686 |
Remote Similarity |
NPD6764 |
Approved |
0.6686 |
Remote Similarity |
NPD6765 |
Approved |
0.6684 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6684 |
Remote Similarity |
NPD8319 |
Approved |
0.6667 |
Remote Similarity |
NPD7714 |
Approved |
0.6667 |
Remote Similarity |
NPD7715 |
Approved |
0.6648 |
Remote Similarity |
NPD6534 |
Approved |
0.6648 |
Remote Similarity |
NPD6535 |
Approved |
0.6647 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6647 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD6799 |
Approved |
0.6644 |
Remote Similarity |
NPD5667 |
Approved |
0.6631 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6623 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6622 |
Remote Similarity |
NPD3972 |
Approved |
0.6618 |
Remote Similarity |
NPD1929 |
Approved |
0.6618 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD1930 |
Approved |
0.6605 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6581 |
Remote Similarity |
NPD230 |
Phase 1 |
0.657 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6568 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6568 |
Remote Similarity |
NPD3749 |
Approved |
0.6566 |
Remote Similarity |
NPD6385 |
Approved |
0.6566 |
Remote Similarity |
NPD6386 |
Approved |
0.6566 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6562 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6562 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6558 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6554 |
Remote Similarity |
NPD1281 |
Approved |
0.6552 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6543 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6543 |
Remote Similarity |
NPD7698 |
Approved |
0.6543 |
Remote Similarity |
NPD7697 |
Approved |
0.6541 |
Remote Similarity |
NPD1989 |
Approved |
0.6536 |
Remote Similarity |
NPD6785 |
Approved |
0.6536 |
Remote Similarity |
NPD6784 |
Approved |
0.6536 |
Remote Similarity |
NPD7095 |
Approved |
0.6533 |
Remote Similarity |
NPD1876 |
Approved |
0.6532 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6532 |
Remote Similarity |
NPD7997 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6531 |
Remote Similarity |
NPD17 |
Approved |
0.6529 |
Remote Similarity |
NPD919 |
Approved |
0.6527 |
Remote Similarity |
NPD1934 |
Approved |
0.6525 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD920 |
Approved |
0.6515 |
Remote Similarity |
NPD1202 |
Approved |
0.6514 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.651 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.651 |
Remote Similarity |
NPD6637 |
Approved |
0.651 |
Remote Similarity |
NPD7874 |
Approved |
0.6508 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6508 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6507 |
Remote Similarity |
NPD9545 |
Approved |
0.6506 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6505 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6503 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD2569 |
Approved |
0.6497 |
Remote Similarity |
NPD2567 |
Approved |
0.6494 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6494 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6494 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6489 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6478
|
Remote Similarity |
NPD6005 |
Phase 3 |